Oaktree Acquisition Corp. III Life Sciences
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Oaktree Acquisition Corp. III Life Sciences
Blank Checks, SIC 6770
Oaktree Acquisition Corp. III Life Sciences is a blank check company established to execute a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The entity focuses its acquisition efforts primarily on companies within the healthcare and healthcare-related industries, with particular interest in biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors. Because the company has not yet consummated a transaction, it does not currently provide commercial products or services to external customers.
The company operates as a Cayman Islands exempted entity without active commercial operations or dedicated store footprints. It directs its target search primarily toward enterprises located in North America, the United Kingdom, and Western Europe. Its organizational activities and strategic initiatives are supported through its affiliation with Oaktree Capital, an investment management firm headquartered in Los Angeles, California.
Summary of the business section of Oaktree Acquisition Corp. III Life Sciences's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Oaktree Acquisition Corp. III Life Sciences
- Founded
- 2024
- Headquarters
- Los Angeles, CA
- Address
- 333 South Grand Avenue, 28th Floor 90071
- Phone
- (213) 830-6300
- Employees
- 1,500, Dec 31, 2025
- Industry
- Blank Checks
- Incorporated in
- E9
- Fiscal year ends
- December 31
- Auditor
- WithumSmith+Brown, PC, New York, New York
Stock & identifiers
- Ticker
- OACC
- Other tickers
- OACCU, OACCW
- Exchange
- Nasdaq
- IPO date
- Oct 24, 2024
- Shares outstanding
- 25M, Aug 12, 2026
- Public float
- $200.63M, Dec 31, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 2029769
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| George Arthur Martinez | Chief Financial Officer | – |
| Thomas Sweeney | Chief Financial Officer | – |
| David A. Berry | Director | – |
Employees
Headcount reported in annual reports
“Oaktree is a leading global investment management firm founded in 1995 and headquartered in Los Angeles, California, with over 1,500 employees throughout offices in 26 cities in 18 countries (including offices of affiliates of Oaktree-managed funds).”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 24, 2024 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 23, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |